The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Fosfomycin Sodium Market Research Report 2024

Global Fosfomycin Sodium Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1535769

No of Pages : 94

Synopsis
Fosfomycin sodium is an antibiotic medication used to treat various bacterial infections. It belongs to the class of antibiotics known as phosphonic acids and acts by inhibiting the synthesis of bacterial cell walls. Fosfomycin is often used for the treatment of urinary tract infections (UTIs) caused by susceptible bacteria.
The global Fosfomycin Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global rise in antibiotic resistance is a significant factor impacting the antibiotic market. Fosfomycin sodium, as an antibiotic, may see variations in demand based on its effectiveness against resistant strains of bacteria.
This report aims to provide a comprehensive presentation of the global market for Fosfomycin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fosfomycin Sodium.
Report Scope
The Fosfomycin Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fosfomycin Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fosfomycin Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Northeast Pharma
Ercros
Shin Poong Pharm
Sundent Pharm Group
Hubei Xunda Pharmaceutical
FarmaSino Pharmaceutical
National Analytical Corporation
New Asia Pharma
Dorrapharma
Segment by Type
Tablets
Injection
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fosfomycin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fosfomycin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Fosfomycin Sodium Market Overview
1.1 Product Overview and Scope of Fosfomycin Sodium
1.2 Fosfomycin Sodium Segment by Type
1.2.1 Global Fosfomycin Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Injection
1.3 Fosfomycin Sodium Segment by Application
1.3.1 Global Fosfomycin Sodium Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Fosfomycin Sodium Market Size Estimates and Forecasts
1.4.1 Global Fosfomycin Sodium Revenue 2019-2030
1.4.2 Global Fosfomycin Sodium Sales 2019-2030
1.4.3 Global Fosfomycin Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fosfomycin Sodium Market Competition by Manufacturers
2.1 Global Fosfomycin Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fosfomycin Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fosfomycin Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Fosfomycin Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fosfomycin Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fosfomycin Sodium, Product Type & Application
2.7 Fosfomycin Sodium Market Competitive Situation and Trends
2.7.1 Fosfomycin Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fosfomycin Sodium Players Market Share by Revenue
2.7.3 Global Fosfomycin Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fosfomycin Sodium Retrospective Market Scenario by Region
3.1 Global Fosfomycin Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fosfomycin Sodium Global Fosfomycin Sodium Sales by Region: 2019-2030
3.2.1 Global Fosfomycin Sodium Sales by Region: 2019-2024
3.2.2 Global Fosfomycin Sodium Sales by Region: 2025-2030
3.3 Global Fosfomycin Sodium Global Fosfomycin Sodium Revenue by Region: 2019-2030
3.3.1 Global Fosfomycin Sodium Revenue by Region: 2019-2024
3.3.2 Global Fosfomycin Sodium Revenue by Region: 2025-2030
3.4 North America Fosfomycin Sodium Market Facts & Figures by Country
3.4.1 North America Fosfomycin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fosfomycin Sodium Sales by Country (2019-2030)
3.4.3 North America Fosfomycin Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fosfomycin Sodium Market Facts & Figures by Country
3.5.1 Europe Fosfomycin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fosfomycin Sodium Sales by Country (2019-2030)
3.5.3 Europe Fosfomycin Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fosfomycin Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Fosfomycin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fosfomycin Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Fosfomycin Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fosfomycin Sodium Market Facts & Figures by Country
3.7.1 Latin America Fosfomycin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fosfomycin Sodium Sales by Country (2019-2030)
3.7.3 Latin America Fosfomycin Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fosfomycin Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Fosfomycin Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fosfomycin Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fosfomycin Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Fosfomycin Sodium Sales by Type (2019-2030)
4.1.1 Global Fosfomycin Sodium Sales by Type (2019-2024)
4.1.2 Global Fosfomycin Sodium Sales by Type (2025-2030)
4.1.3 Global Fosfomycin Sodium Sales Market Share by Type (2019-2030)
4.2 Global Fosfomycin Sodium Revenue by Type (2019-2030)
4.2.1 Global Fosfomycin Sodium Revenue by Type (2019-2024)
4.2.2 Global Fosfomycin Sodium Revenue by Type (2025-2030)
4.2.3 Global Fosfomycin Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Fosfomycin Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fosfomycin Sodium Sales by Application (2019-2030)
5.1.1 Global Fosfomycin Sodium Sales by Application (2019-2024)
5.1.2 Global Fosfomycin Sodium Sales by Application (2025-2030)
5.1.3 Global Fosfomycin Sodium Sales Market Share by Application (2019-2030)
5.2 Global Fosfomycin Sodium Revenue by Application (2019-2030)
5.2.1 Global Fosfomycin Sodium Revenue by Application (2019-2024)
5.2.2 Global Fosfomycin Sodium Revenue by Application (2025-2030)
5.2.3 Global Fosfomycin Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Fosfomycin Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Corporation Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck KGaA Fosfomycin Sodium Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Northeast Pharma
6.2.1 Northeast Pharma Corporation Information
6.2.2 Northeast Pharma Description and Business Overview
6.2.3 Northeast Pharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Northeast Pharma Fosfomycin Sodium Product Portfolio
6.2.5 Northeast Pharma Recent Developments/Updates
6.3 Ercros
6.3.1 Ercros Corporation Information
6.3.2 Ercros Description and Business Overview
6.3.3 Ercros Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ercros Fosfomycin Sodium Product Portfolio
6.3.5 Ercros Recent Developments/Updates
6.4 Shin Poong Pharm
6.4.1 Shin Poong Pharm Corporation Information
6.4.2 Shin Poong Pharm Description and Business Overview
6.4.3 Shin Poong Pharm Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shin Poong Pharm Fosfomycin Sodium Product Portfolio
6.4.5 Shin Poong Pharm Recent Developments/Updates
6.5 Sundent Pharm Group
6.5.1 Sundent Pharm Group Corporation Information
6.5.2 Sundent Pharm Group Description and Business Overview
6.5.3 Sundent Pharm Group Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sundent Pharm Group Fosfomycin Sodium Product Portfolio
6.5.5 Sundent Pharm Group Recent Developments/Updates
6.6 Hubei Xunda Pharmaceutical
6.6.1 Hubei Xunda Pharmaceutical Corporation Information
6.6.2 Hubei Xunda Pharmaceutical Description and Business Overview
6.6.3 Hubei Xunda Pharmaceutical Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hubei Xunda Pharmaceutical Fosfomycin Sodium Product Portfolio
6.6.5 Hubei Xunda Pharmaceutical Recent Developments/Updates
6.7 FarmaSino Pharmaceutical
6.6.1 FarmaSino Pharmaceutical Corporation Information
6.6.2 FarmaSino Pharmaceutical Description and Business Overview
6.6.3 FarmaSino Pharmaceutical Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 FarmaSino Pharmaceutical Fosfomycin Sodium Product Portfolio
6.7.5 FarmaSino Pharmaceutical Recent Developments/Updates
6.8 National Analytical Corporation
6.8.1 National Analytical Corporation Corporation Information
6.8.2 National Analytical Corporation Description and Business Overview
6.8.3 National Analytical Corporation Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 National Analytical Corporation Fosfomycin Sodium Product Portfolio
6.8.5 National Analytical Corporation Recent Developments/Updates
6.9 New Asia Pharma
6.9.1 New Asia Pharma Corporation Information
6.9.2 New Asia Pharma Description and Business Overview
6.9.3 New Asia Pharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 New Asia Pharma Fosfomycin Sodium Product Portfolio
6.9.5 New Asia Pharma Recent Developments/Updates
6.10 Dorrapharma
6.10.1 Dorrapharma Corporation Information
6.10.2 Dorrapharma Description and Business Overview
6.10.3 Dorrapharma Fosfomycin Sodium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Dorrapharma Fosfomycin Sodium Product Portfolio
6.10.5 Dorrapharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fosfomycin Sodium Industry Chain Analysis
7.2 Fosfomycin Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fosfomycin Sodium Production Mode & Process
7.4 Fosfomycin Sodium Sales and Marketing
7.4.1 Fosfomycin Sodium Sales Channels
7.4.2 Fosfomycin Sodium Distributors
7.5 Fosfomycin Sodium Customers
8 Fosfomycin Sodium Market Dynamics
8.1 Fosfomycin Sodium Industry Trends
8.2 Fosfomycin Sodium Market Drivers
8.3 Fosfomycin Sodium Market Challenges
8.4 Fosfomycin Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’